Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter
- PMID: 37823639
- PMCID: PMC10649087
- DOI: 10.1128/aac.00752-23
Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter
Abstract
Campylobacter species infections in immunocompromised patients have the potential to progress to bacteremia and other extra-intestinal diseases. There is a sparsity of robust data, including antibiotic susceptibility data for contemporary agents, upon which to base treatment decisions. Moreover, intrinsic antimicrobial resistance in Campylobacter spp. further limits treatment options. The current publication by Bonilla-Moreno et al. elaborates on this clinical dilemma through the development, treatment, and molecular investigation of the putative mechanisms of carbapenem resistance in an immunocompromised patient with Campylobacter coli bacteremia.
Keywords: Campylobacter; multidrug resistance.
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient.Antimicrob Agents Chemother. 2023 Nov;67(11):e0027223. doi: 10.1128/aac.00272-23. Epub 2023 Jun 26. Antimicrob Agents Chemother. 2023. PMID: 37358413 Free PMC article.
References
-
- Montgomery MP, Robertson S, Koski L, Salehi E, Stevenson LM, Silver R, Sundararaman P, Singh A, Joseph LA, Weisner MB, Brandt E, Prarat M, Bokanyi R, Chen JC, Folster JP, Bennett CT, Francois Watkins LK, Aubert RD, Chu A, Jackson J, Blanton J, Ginn A, Ramadugu K, Stanek D, DeMent J, Cui J, Zhang Y, Basler C, Friedman CR, Geissler AL, Crowe SJ, Dowell N, Dixon S, Whitlock L, Williams I, Jhung MA, Nichols MC, de Fijter S, Laughlin ME. 2018. Multidrug-resistant Campylobacter jejuni outbreak linked to puppy exposure — United States, 2016–2018. MMWR Morb Mortal Wkly Rep 67:1032–1035. doi:10.15585/mmwr.mm6737a3 - DOI - PMC - PubMed
-
- Bonilla-Moreno M, Torrecillas M, Laporte-Amargos J, González-Díaz A, Mussetti A, Tubau F, Gudiol C, Domínguez MA, Martí S, Rodríguez-Sevilla G, Ardanuy C. 2023. Development of meropenem resistance in a multidrug-resistant Campylobacter coli strain causing recurrent bacteremia in a hematological malignancy patient. Antimicrob Agents Chemother:e0027223. doi:10.1128/aac.00272-23 - DOI - PMC - PubMed
-
- "Campylobacter". WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/campylobacter. Retrieved 5 July 2023
-
- Campylobacter (campylobacteriosis): antibiotic resistance. CDC. Available from: https://www.cdc.gov/campylobacter/campy-antibiotic-resistance.html. Retrieved 5 July 2023
-
- Schiaffino F, Kosek MN. 2020. Intestinal and extra-intestinal manifestations of Campylobacter in the immunocompromised host. Curr Treat Options Infect Dis 12:361–374. doi:10.1007/s40506-020-00243-4 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous